Dr Joseph Geraci
Dr Joseph Geraci is Co-Founder and Chief Scientific and Technical Officer at NetraMark, where he led the development of NetraAI, an artificial intelligence (AI) platform that uses mathematical methods to identify clinically meaningful patient subpopulations within small, complex datasets. With postdoctoral training in machine learning, oncology and neuropsychiatry, he has focused his career on developing mathematical and AI methods to better understand differences between patient populations and improve decision-making in drug development.
Contact info
- Website:
- https://www.netramark.com/
ArticleFinding drug targets through the noise of complex disease
The strongest disease signal may not point to the best drug target. AI could help researchers identify what matters within complex biological networks.